Arcutis Biotherapeutics, Inc. (ARQT)
25.55
-1.45
(-5.37%)
USD |
NASDAQ |
Nov 06, 16:00
25.56
+0.01
(+0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics Free Cash Flow : 59.71M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 59.71M |
| June 30, 2026 | 39.15M |
| March 31, 2026 | 16.92M |
| December 31, 2025 | -16.31M |
| September 30, 2025 | -48.24M |
| June 30, 2025 | -81.32M |
| March 31, 2025 | -116.69M |
| December 31, 2024 | -117.30M |
| September 30, 2024 | -167.80M |
| June 30, 2024 | -177.02M |
| March 31, 2024 | -198.66M |
| December 31, 2023 | -247.48M |
| September 30, 2023 | -262.42M |
| June 30, 2023 | -293.58M |
| March 31, 2023 | -288.88M |
| Date | Value |
|---|---|
| December 31, 2022 | -265.55M |
| September 30, 2022 | -246.33M |
| June 30, 2022 | -212.15M |
| March 31, 2022 | -185.96M |
| December 31, 2021 | -175.62M |
| September 30, 2021 | -155.90M |
| June 30, 2021 | -149.16M |
| March 31, 2021 | -139.06M |
| December 31, 2020 | -113.35M |
| September 30, 2020 | -99.26M |
| June 30, 2020 | -75.93M |
| March 31, 2020 | -58.33M |
| December 31, 2019 | -44.53M |
| September 30, 2019 | -32.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | -- |
| ADMA Biologics, Inc. | 132.60M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 18.90M |
| Cash from Investing (Quarterly) | -22.08M |
| Cash from Financing (Quarterly) | 2.453M |
| Free Cash Flow Per Share (Quarterly) | 0.1374 |
| Free Cash Flow to Equity (Quarterly) | 9.118M |
| Free Cash Flow to Firm (Quarterly) | 21.70M |
| Free Cash Flow Yield | 1.74% |